Myocarditis

Overview

Myocarditis is an inflammation of the myocardium, the heart muscle itself. Under normal circumstances, the heart muscle contracts rhythmically and forcefully to pump blood throughout the body. When inflammation disrupts this function, the heart may be unable to pump adequately, rhythm disturbances can develop, and in severe cases acute heart failure may occur.

Myocarditis can affect people of any age, but it is most commonly diagnosed in young and middle-aged individuals, particularly young men. In mild cases, the person experiences only fatigue and mild chest discomfort and usually recovers fully. In severe cases, cardiac function can deteriorate rapidly, leading to life-threatening complications including sudden cardiac death. For this reason, myocarditis must be taken seriously and never dismissed.

Viral infections are the most frequent cause. Coxsackievirus B, influenza, COVID-19, and many other viruses can involve the heart muscle. Viruses can damage cardiac cells directly or trigger an immune response in which the body's own defenses attack heart tissue. Less common bacterial, autoimmune, and drug-induced forms also exist.

Myocarditis can be diagnostically challenging; its symptoms often overlap with those of a heart attack and other cardiac conditions. Accurate diagnosis requires comprehensive evaluation. When the underlying cause is identified and treated, and adequate rest is ensured, the majority of patients achieve full recovery.

Symptoms

Myocarditis symptoms range from entirely absent or barely noticeable to severe and life-threatening, depending on the extent of cardiac involvement. In mild cases, symptoms may be so subtle that the episode goes unrecognized. In severe cases, onset can be sudden and dramatic.

Myocarditis symptoms include the following:

• Chest pain or pressure. A sharp, burning, or pressure-like discomfort in the center or left side of the chest may be felt. It can worsen with breathing or physical activity. Because it can closely mimic a heart attack, urgent medical evaluation is essential.
• Shortness of breath. When the heart muscle's pumping capacity is reduced, less blood reaches the lungs and breathing becomes difficult. Initially noticeable only with exertion, breathlessness can occur at rest in severe cases. Worsening breathlessness when lying flat may indicate developing heart failure.
• Palpitations and arrhythmias. Inflammation of the heart muscle can disrupt the electrical conduction system, causing rapid, slow, or irregular heartbeats. Palpitations are perceived as fluttering, pounding, or an irregular pulse. Serious arrhythmias can cause sudden loss of consciousness and sudden cardiac death.
• Fatigue and weakness. Marked, unexplained fatigue is one of the most common features of myocarditis. As the heart's output falls, reduced blood flow to the entire body produces a pervasive sense of exhaustion. Daily activities become progressively more difficult to sustain.
• Fever. Fever is common, particularly in viral cases. It may be part of the preceding or coexisting viral illness rather than a direct consequence of myocardial inflammation.
• Leg and ankle swelling. When heart failure develops, fluid accumulates in the body. Swelling of the legs, ankles, and sometimes the abdomen becomes apparent.
• Dizziness and fainting. Reduced cardiac output or serious arrhythmias can diminish blood flow to the brain, causing lightheadedness, dizziness, and syncope (fainting).
• Flu-like symptoms. Particularly at onset, muscle aches, joint pain, headache, and a runny nose reflecting an underlying viral illness may be present. This can cause myocarditis to be initially mistaken for a routine viral illness.

Myocarditis symptoms can sometimes be so mild that the person assumes they are recovering from a minor illness. However, chest pain, palpitations, or abnormal fatigue occurring during or after exercise (particularly in young and active individuals) should always be taken seriously and investigated without delay.

When to See a Doctor

Myocarditis can progress rapidly. Prompt medical evaluation once symptoms appear can be life-saving.

Schedule urgent medical evaluation if:

• You develop chest pain, palpitations, or shortness of breath shortly after a viral infection
• You experience unusual fatigue, chest discomfort, or palpitations during or after exercise
• You have rapidly worsening, unexplained weakness and reduced exercise tolerance
• Swelling has developed in your legs or ankles
• You have fever accompanied by chest pain or palpitations

Call emergency services immediately if you experience:

• Sudden, severe chest pain, especially if it radiates to the arm or jaw
• Severe shortness of breath, particularly if you cannot breathe while lying flat
• Fainting or a sensation that you are about to faint
• Very rapid or very irregular heartbeat
• Confusion or sudden altered consciousness

Causes

Myocarditis can arise from a variety of different underlying causes. Damage to the heart muscle occurs through two main mechanisms: direct destruction of cardiac cells by microorganisms, or an immune response in which the body's defenses mistakenly attack its own heart tissue.

Possible causes of myocarditis include the following:

• Viral infections. This is the most common cause. Coxsackievirus B is the best-known causative agent. Other important viruses include influenza, adenovirus, parvovirus B19, Epstein-Barr virus, cytomegalovirus, hepatitis C virus, and HIV. COVID-19 infection has also been associated with myocarditis. Rare cases of myocarditis following mRNA COVID-19 vaccination have been reported, predominantly in young men, most commonly after the second dose; the great majority of these cases are mild and self-limiting.
• Bacterial infections. Streptococcus, Staphylococcus, Corynebacterium diphtheriae (diphtheria), and Borrelia burgdorferi (the agent of Lyme disease) can cause myocarditis. Bacterial myocarditis generally follows a more severe course than its viral counterpart.
• Autoimmune diseases. Systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis, and giant cell myocarditis can involve the myocardium through immune-mediated mechanisms. Autoimmune myocarditis warrants particular attention given its tendency toward a refractory and relapsing course.
• Medications and toxins. Certain chemotherapy agents (particularly anthracyclines) immune checkpoint inhibitors, clozapine, and cocaine can cause myocarditis. Chronic excessive alcohol consumption damages the heart muscle and predisposes to toxic myocarditis.
• Vaccine-associated myocarditis. Rare cases of myocarditis following mRNA COVID-19 vaccines have been documented, primarily in males aged 16–30 and most often after the second dose. The overwhelming majority of cases are mild and resolve spontaneously with rest.
• Parasitic and fungal infections. Trypanosoma cruzi (the causative agent of Chagas disease) is the most important parasitic cause of myocarditis and is endemic in parts of South America. Toxoplasmosis can cause myocarditis in immunocompromised patients.
• Idiopathic myocarditis. In some cases, no definitive cause is identified despite thorough investigation. These cases are classified as idiopathic, and an undetected viral trigger is the most probable explanation.

Risk Factors

Several factors are associated with an increased risk of developing myocarditis:

• Young male sex. While myocarditis can occur at any age, it is most frequently diagnosed in men between 20 and 40 years of age. Testosterone's modulating effect on immune responses is thought to contribute to this disparity.
• Recent viral infection. A history of upper respiratory tract illness or influenza in the 1–4 weeks before cardiac symptoms develop should raise clinical suspicion for myocarditis.
• High-intensity physical activity. Exercising vigorously during an active infection or the recovery period increases myocarditis risk and can deepen existing cardiac injury. Abstaining from sport during and for a period after viral illness is therefore strongly recommended.
• Immunosuppression. HIV infection, post-transplant immunosuppressive therapy, and prolonged corticosteroid use increase susceptibility to infectious myocarditis.
• Autoimmune diseases. Systemic conditions such as lupus, rheumatoid arthritis, and sarcoidosis increase the likelihood of myocardial involvement.
• Certain medication and toxin exposures. Cardiotoxic chemotherapeutic agents, immune checkpoint inhibitors, and heavy alcohol use are the principal modifiable risk factors in this category.

Diagnosis

Myocarditis can be diagnostically challenging; its presentation frequently overlaps with that of a heart attack and other cardiac conditions. Diagnosis is established through a combination of clinical assessment, laboratory testing, and imaging.

Diagnostic methods include the following:

• Medical history and physical examination. The onset and evolution of symptoms and any preceding illness are carefully explored. Heart rate, rhythm, murmurs, and signs of heart failure are assessed on examination. A history of recent viral illness is a valuable diagnostic clue.
• Blood tests. Troponin I and T are the most important biomarkers of myocardial injury; they are elevated in myocarditis. Inflammatory markers (CRP, ESR) confirm active inflammation. BNP and NT-proBNP indicate whether heart failure is developing. Viral serology, autoimmune markers, and a full blood count are ordered to investigate the underlying cause.
• Electrocardiography (ECG). A range of ECG abnormalities may be seen in myocarditis: sinus tachycardia, ST-segment changes, T-wave abnormalities, and conduction disturbances. Because these findings can closely resemble those of a heart attack, additional tests are required for definitive differentiation.
• Echocardiography. This evaluates cardiac dimensions, wall motion, and pumping function (ejection fraction). In myocarditis, regional or global wall motion abnormalities, dilated cardiac chambers, and a reduced ejection fraction may be identified. Pericardial fluid and valve function are also assessed.
• Cardiac MRI. This is the gold-standard non-invasive diagnostic tool for myocarditis. T2-weighted sequences demonstrate edema and active inflammation; late gadolinium enhancement reveals fibrosis and permanent injury. Cardiac MRI precisely characterizes the location, extent, and severity of myocardial damage, and is valuable both for confirming the diagnosis and for prognostic assessment.
• Coronary angiography. When elevated troponin and ECG changes mimic a heart attack, coronary angiography may be required to exclude coronary artery obstruction. Open coronary arteries in this setting point toward a non-ischemic cause and support the diagnosis of myocarditis.
• Endomyocardial biopsy. This is the only method capable of providing a definitive histological diagnosis of myocarditis. However, because it is invasive and subject to sampling error, it is not performed routinely. It is considered in cases of rapidly deteriorating heart failure, life-threatening arrhythmias, or failure to respond to standard therapy. Biopsy specimens are evaluated by histology, culture, and PCR.

Treatment

Myocarditis treatment is tailored to disease severity, the underlying cause, and the presence of complications. Mild cases are managed with rest and supportive care; severe cases may require intensive care and advanced circulatory support.

Treatment options include the following:

• Physical activity restriction and rest. This is the most fundamental component of management. Exercise during active myocarditis deepens cardiac injury and substantially increases the risk of arrhythmias and sudden death. Competitive sport and vigorous physical activity must be avoided until symptoms have fully resolved and cardiac function has normalized; typically for a minimum of 3–6 months. This restriction applies to all patients, including athletes.
• Heart failure treatment. When left ventricular function is impaired, standard heart failure medications are initiated. ACE inhibitors or ARBs protect the heart and help prevent adverse remodeling. Beta-blockers regulate heart rate and reduce oxygen demand. Diuretics relieve fluid overload and reduce breathlessness.
• Arrhythmia management. Arrhythmias are treated with antiarrhythmic medications or, when necessary, electrical cardioversion. Life-threatening arrhythmias require intensive care monitoring. Persistent conduction system damage may necessitate temporary or permanent pacemaker implantation.
• Treatment of the underlying cause. Bacterial myocarditis requires antibiotics; Chagas disease requires antiparasitic therapy; autoimmune myocarditis is managed with immunosuppressive treatment. Drug-induced cases require discontinuation of the offending agent.
• Immunosuppressive therapy. Corticosteroids and other immunosuppressive agents can improve outcomes in autoimmune and giant cell myocarditis. Their role in viral myocarditis remains controversial; use during active viral replication may be harmful and requires careful case-by-case assessment.
• Mechanical circulatory support. When cardiac function is severely compromised, temporary mechanical support devices (including intra-aortic balloon pump, ECMO (extracorporeal membrane oxygenation), or a ventricular assist device) may be used to sustain circulation while the heart recovers.
• Heart transplantation. In cases of end-stage heart failure that does not respond to medical therapy and mechanical support, heart transplantation may be considered as a last resort.

Complications

With appropriate treatment, myocarditis resolves without complications in most patients. However, a subset develop serious and potentially permanent complications:

• Dilated cardiomyopathy. This is the most common long-term complication. Chronic inflammation weakens the heart muscle and causes the cardiac chambers to enlarge, permanently impairing pumping function. This condition may lead to chronic heart failure requiring lifelong treatment.
• Chronic heart failure. Permanent myocardial damage can evolve into chronic heart failure over time. Breathlessness, edema, and exercise intolerance become ongoing problems. Severe cases may ultimately require heart transplantation.
• Sudden cardiac death. This is the most feared complication of myocarditis. During active myocarditis, life-threatening ventricular arrhythmias (particularly ventricular fibrillation) can cause sudden death. The risk is highest in young athletes who exercise intensely without knowing they have myocarditis.
• Heart block and conduction abnormalities. Inflammatory damage to the cardiac conduction system can produce varying degrees of heart block. Complete heart block causes sudden syncope and may require emergency pacemaker implantation.
• Pericarditis. The pericardium may become inflamed alongside the myocardium; a condition termed myopericarditis. Chest pain and pericardial effusion may accompany this presentation.
• Thromboembolic events. Blood clots can form within the dilated and weakly contracting cardiac chambers. These clots may travel to the brain, causing stroke, or to other organs, causing ischemic injury.

Living with Myocarditis

A myocarditis diagnosis can be especially difficult for active and athletic individuals. It is important to know, however, that the vast majority of people with myocarditis recover fully, and that returning to normal life, including sport, is achievable with proper management.

Physical Activity and Return to Sport

Activity restriction during recovery both accelerates healing and prevents serious complications. Competitive sport must be avoided until symptoms have fully resolved, troponin has normalized, ECG and echocardiography have returned to normal limits, and (ideally) cardiac MRI has confirmed resolution of inflammation. This process typically takes a minimum of 3–6 months. The decision to return to sport must be made by your cardiologist, not by the patient. Light walking and routine daily activities can be cautiously reintroduced during recovery with medical guidance.

Medication Adherence

Take heart failure medications for the full duration prescribed, even if you feel well. Do not discontinue medications without your doctor's approval; this decision should never be made unilaterally. Report any side effects promptly, as alternatives are usually available.

Protecting Against Viral Infections

To reduce the risk of viral triggers, practice good hand hygiene, avoid crowded environments during peak infection seasons, and stay up to date with recommended vaccinations including the influenza vaccine. Crucially, do not exercise while symptomatic with a viral illness; fever, malaise, or muscle aches are signals to rest, not push through.

Alcohol and Smoking

Alcohol directly damages the heart muscle and impairs recovery from myocarditis. Avoid alcohol entirely during the recovery period and limit intake permanently thereafter. Quitting smoking benefits both myocardial health and overall cardiovascular well-being.

Regular Follow-up

Ongoing cardiology follow-up after myocarditis is essential. Troponin levels, echocardiography, and where indicated cardiac MRI should confirm complete recovery. Seek medical attention without delay if symptoms recur or worsen. Annual echocardiography is recommended long-term to monitor for the development of cardiomyopathy.

Preparing for Your Appointment

Coming prepared to your appointment helps ensure rapid and accurate diagnosis and the most appropriate treatment plan.

What you can do:

• Note when symptoms such as chest pain, palpitations, or breathlessness began and how they have evolved
• Describe any viral illness you experienced in the 1–4 weeks before symptoms started
• List all current medications, chemotherapy agents, and supplements
• Describe your exercise habits and any recent changes in training intensity
• Report your vaccination history, including COVID-19 vaccines and dates
• Mention any family history of heart disease or sudden cardiac death
• Write down your questions in advance

Questions you may wish to ask your doctor:

• Is the myocarditis diagnosis confirmed, and has a heart attack been excluded?
• How severe is the cardiac damage, and what is my current heart function?
• How long must I avoid exercise?
• When can I return to sport or strenuous activity?
• Will I make a full recovery, or is permanent damage possible?
• Which symptoms should prompt me to seek emergency care?
• Is there a hereditary component that my family should know about?
• How often should I come for follow-up?

Questions your doctor may ask:

• When did symptoms begin, and how have they progressed?
• Did you have a viral illness in the weeks before symptoms started?
• Do symptoms worsen during or after exercise?
• Do you have a known heart condition or autoimmune disease?
• What medications are you currently taking?
• Do you exercise regularly? What type and how intensely?
• Is there a family history of sudden cardiac death or early-onset heart disease?
• Do you use alcohol or recreational drugs?